Manufacturer record
Marc Laboratories Ltd. (Unit III): regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Marc Laboratories Ltd. (Unit III) (Himachal Pradesh) were declared Not of Standard Quality between February 2026 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MFS-117, Iron Sucrose Injection USP (exp Sep 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to U.S.P with respect to test for 'Alkalinity' and 'pH'. Listed in the September 2026 alert.
Records by type
11 records linked to Marc Laboratories Ltd. (Unit III) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Iron Sucrose Injection USP | Batch MFS-117Mfg Oct 2025 · Exp Sep 2027 | The sample does not conform to U.S.P with respect to test for 'Alkalinity' and 'pH'pH | CDL, KolkataCDSCO lab | Sep 2026 |
| Iron Sucrose Injection USP | Batch MFS-134Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to U.S.P with respect to the Test for "pH' and 'AlkalinitypH | CDL, KolkataCDSCO lab | Sep 2026 |
| Iron Sucrose Injection USP | Batch MFS-129Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to U.S.P with respect to test for "Alkalinity" and "pH".pH | CDL, KolkataCDSCO lab | Sep 2026 |
| Iron Sucrose Injection USP | Batch MFS-133Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to U.S.P with respect to test for 'Alkalinity' and 'pH'pH | CDL, KolkataCDSCO lab | Sep 2026 |
| Iron Sucrose Injection USP | Batch MFS-136Mfg Jan 2026 · Exp Dec 2027 | The sample does not conform to U.S.P with respect to test for 'pH' and 'Alkalinity'.pH | CDL, KolkataCDSCO lab | Sep 2026 |
| Ondansetron Injection IP-2mg/ml | Batch TON-102Mfg Nov 2025 · Exp Oct 2027 | pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab | May 2026 |
| Iron Sucrose Injection USP | Batch MFS-124Mfg Nov 2025 · Exp Oct 2027 | The sample does not conform to U.S.P with respect to test for pH and AlkalinitypH | CDL, KolkataCDSCO lab | May 2026 |
| Iron Sucrose Injection USP | Batch MFS-122Mfg Nov 2025 · Exp Oct 2027 | The sample does not conform to U.S.P with respect to test for 'pH' and 'Alkalinity'pH | CDL, KolkataCDSCO lab | May 2026 |
| Tranexamic Acid Injection I.P, | Batch TG-156Mfg Aug 2025 · Exp Jul 2027 | The sample received does not conform to I.P. 2022 specification with respect to the test for bacterial endotoxins only.Bacterial endotoxins | CDTL, HyderabadCDSCO lab | Feb 2026 |
| Ceftriaxone Injection IP 1000 mg | Batch PCD-120Mfg Oct 2024 · Exp Apr 2027 | The sample does not conform to claim as per IP 2022 in respect to the Test of Particulate matterParticulate matter | RDTL, ChandigarhCDSCO lab | Feb 2026 |
| Amoxycillin and Potassium Clavulanate Injection IP 500 mg +100 mg | Batch TAC-612Mfg May 2025 · Exp Apr 2030 | The sample received does not conform to I.P. 2022 specification with respect to the Assay for the content of potassium clavulanate equivalent to clavulanic acid only.Assay | CDTL, HyderabadCDSCO lab | Feb 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.